01A LifeMD Teal Blue.png
LifeMD Announces Expected Record Revenue of $18.2M for Q1’21, Up 323% Vs. Q1’20, Due to Growth in Subscriptions and Patient Acquisition
19 avr. 2021 07h30 HE | LifeMD, Inc.
NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced expected record revenue of $18.2M for Q1’21....
01A LifeMD Teal Blue.png
Short-Seller’s Note is Short on Credibility, LifeMD Says
16 avr. 2021 10h57 HE | LifeMD, Inc.
NEW YORK, April 16, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, released a letter to shareholders today in response to an...
01A LifeMD Teal Blue.png
LifeMD Responds to Anonymous Short “Report”
15 avr. 2021 07h30 HE | LifeMD, Inc.
NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) is a leading direct-to-patient telehealth company. Yesterday, an unsigned note making false claims against...
01A LifeMD Teal Blue.png
LifeMD Launches NavaMD™ Adding Direct-to-Patient Clinical Skincare Services to its Portfolio of Personalized Telehealth Brands
07 avr. 2021 08h31 HE | LifeMD, Inc.
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the successful launch of NavaMD™. The NavaMD...
01A LifeMD Teal Blue.png
LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million
29 mars 2021 16h05 HE | LifeMD, Inc.
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the fourth quarter and full year ended December 31,...
01A LifeMD Teal Blue.png
LifeMD to Host Fourth Quarter and Full Year 2020 Conference Call on Monday, March 29, 2021 at 4:30 p.m. ET
17 mars 2021 08h31 HE | LifeMD, Inc.
NEW YORK, March 17, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will hold a conference call on Monday, March 29, 2021 at 4:30 p.m. Eastern...
01A LifeMD Teal Blue.png
LifeMD Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16 mars 2021 18h00 HE | LifeMD, Inc.
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, announced that the Compensation Committee of the Company’s Board of...
01A LifeMD Teal Blue.png
LifeMD to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
09 mars 2021 07h05 HE | LifeMD, Inc.
NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, has been invited to participate at the 33rd Annual ROTH Growth Conference...
01A LifeMD Teal Blue.png
LifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue
05 mars 2021 07h05 HE | LifeMD, Inc.
NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD) (formerly Conversion Labs), a leading direct-to-patient telehealth company, expects revenue for the first quarter ending...
01A LifeMD Teal Blue.png
Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD
22 févr. 2021 03h30 HE | Conversion Labs, Inc.
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will begin trading at the opening of the market today...